Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
iPSC
Sort By
Newest First
Sign in
1 / 1
1 / 1
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
Shawn Bates; Antonio Fernandez-Perez, Ph.D.
Corning Life Sciences
PAO-12-23-CL-03
Dec 12, 2023
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06
Nov 11, 2022
iPSCs
Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies
CCRM
PR-M11-22-04
Nov 07, 2022
M&A
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
Pluristyx
PR-M10-22-04
Oct 06, 2022
Strategic Alliance
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
FUJIFILM
PR-M01-22-05
Jan 06, 2022
Stem Cells
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
Curi Bio
PR-M03-21-004-1062
Mar 18, 2021
Stem Cells
iPSCs: Moving from Drug Testing to Novel Cell Therapies
Cenk Sumen, Ph.D.
MaxCyte
PAP-Q3-19-CL-030
Oct 28, 2019
